Clinical Application Value of Loplatin and Cisplatin Combined with Fluorouracil in Interventional Therapy of Gastrointestinal Tumors with Liver Metastasis
Objective:To analyze the efficacy of loplatin and cisplatin combined with fluorouracil(5-FU)in interventional therapy of liver metastasis of gastrointestinal tumors.Method:From February 2021 to February 2022,60 patients with gastrointestinal tumors accompanied by liver metastasis in the hospital were selected and randomly assigned to two groups,with 30 cases in each group.The control group was treated with 5-FU combined with cisplatin,while the observation group was treated with loplatin combined with 5-FU.The therapeutic effect was compared.Result:After treatment,it was found that the treatment effective rate of the observation group was higher than that of the control group,the serum tumor marker detection value of the two groups before and after treatment was better than that of the control group,the score of pain and fatigue due to cancer in the observation group was better than that of the control group,and the probability of adverse reactions in the observation group was lower than that of the control group(P<0.05).Conclusion:The combination of loplatin and fluorouracil in the interventional therapy of liver metastasis of gastrointestinal tumors can effectively improve the therapeutic effect.
LobaplatinCisplatin combined with fluorouracilGastrointestinal tumor liver metastasisInterventional therapyClinical application value